6:34 PM
 | 
Mar 10, 2015
 |  BC Extra  |  Company News

Molecular Partners CEO Zahnd to take medical leave

Molecular Partners AG (SIX:MOLN) said CEO Christian Zahnd will soon take temporary medical leave. In the interim, COO Patrick Amstutz and Chairman Jorn Aldag will take over Zahnd's responsibilities.

Molecular Partners raised...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >